Kurt is an executive for over 10 years in the generic and specialty pharmaceutical spaces. Some of his specialties are general management, finance and accounting, sales, business development, quality and regulatory and operations.
A significant proportion of the starting materials that go into the active pharmaceutical ingredients (APIs), as well as other excipients used to make finished drug product, are produced ex-US​.
9 February 2021